Crombe A, Brisse H, Ledoux P, Haddag-Miliani L, Bouhamama A, Taieb S
Eur Radiol. 2018; 29(6):3170-3182.
PMID: 30560359
DOI: 10.1007/s00330-018-5903-3.
Lu X, Zhang L, Zhao H, Chen C, Wang Y, Liu S
Cancer Biol Ther. 2018; 20(2):227-235.
PMID: 30359167
PMC: 6343709.
DOI: 10.1080/15384047.2018.1523853.
Hei Y, Kang L, Yang X, Wang Y, Lu X, Li Y
Oncol Lett. 2017; 15(1):304-314.
PMID: 29285193
PMC: 5738708.
DOI: 10.3892/ol.2017.7286.
Kumar G, Nemade H, Krishnamohan , Fonseca D, Rao L, Subramanyeshwar Rao T
Indian J Surg Oncol. 2017; 8(2):234-239.
PMID: 28546729
PMC: 5427017.
DOI: 10.1007/s13193-016-0550-0.
Wang M, Li J, Huan L, Meng F, Pang Q
Oncol Lett. 2016; 12(2):956-958.
PMID: 27446376
PMC: 4950160.
DOI: 10.3892/ol.2016.4715.
Alveolar soft part sarcoma presenting as a breast metastasis in a patient with a history of thyroid cancer: a case report.
Bychkov A, Sampatanukul P
Int J Clin Exp Pathol. 2015; 8(8):9731-6.
PMID: 26464747
PMC: 4583979.
Clavicular and meningeal alveolar soft part sarcoma: An unusual case and literature review.
James A, Chang L, Levine B, Dry S
J Orthop. 2014; 11(1):48-53.
PMID: 24719534
PMC: 3978739.
DOI: 10.1016/j.jor.2013.12.014.
High-resolution array CGH and gene expression profiling of alveolar soft part sarcoma.
Selvarajah S, Pyne S, Chen E, Sompallae R, Ligon A, Nielsen G
Clin Cancer Res. 2014; 20(6):1521-30.
PMID: 24493828
PMC: 3962657.
DOI: 10.1158/1078-0432.CCR-13-2090.
Alveolar soft part sarcomas: molecular pathogenesis and implications for novel targeted therapies.
Mitton B, Federman N
Sarcoma. 2012; 2012:428789.
PMID: 22566752
PMC: 3337503.
DOI: 10.1155/2012/428789.
Gene expression profiling of alveolar soft-part sarcoma (ASPS).
Stockwin L, Vistica D, Kenney S, Schrump D, Butcher D, Raffeld M
BMC Cancer. 2009; 9:22.
PMID: 19146682
PMC: 2635365.
DOI: 10.1186/1471-2407-9-22.
Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment?.
Genin O, Rechavi G, Nagler A, Ben-Itzhak O, Nazemi K, Pines M
Neoplasia. 2008; 10(9):940-8.
PMID: 18714394
PMC: 2517638.
DOI: 10.1593/neo.08456.
Primary alveolar soft part sarcoma of fibula demonstrating ASPL-TFE3 fusion: a case report and review of the literature.
Aisner S, Beebe K, Blacksin M, Mirani N, Hameed M
Skeletal Radiol. 2008; 37(11):1047-51.
PMID: 18594808
DOI: 10.1007/s00256-008-0540-6.
Alveolar soft-part sarcoma: a review and update.
Folpe A, Deyrup A
J Clin Pathol. 2006; 59(11):1127-32.
PMID: 17071801
PMC: 1860509.
DOI: 10.1136/jcp.2005.031120.
The precrystalline cytoplasmic granules of alveolar soft part sarcoma contain monocarboxylate transporter 1 and CD147.
Ladanyi M, Antonescu C, Drobnjak M, Baren A, Lui M, Golde D
Am J Pathol. 2002; 160(4):1215-21.
PMID: 11943706
PMC: 1867200.
DOI: 10.1016/S0002-9440(10)62548-5.
Alveolar soft part sarcoma: are we at the end or just the beginning of our quest?.
Weiss S
Am J Pathol. 2002; 160(4):1197-9.
PMID: 11943703
PMC: 1867229.
DOI: 10.1016/S0002-9440(10)62545-X.
A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas.
Gattenloehner S, Dockhorn-Dworniczak B, Leuschner I, Vincent A, Muller-Hermelink H, Marx A
J Mol Diagn. 2001; 1(1):23-31.
PMID: 11272905
PMC: 1906880.
DOI: 10.1016/S1525-1578(10)60605-8.
The fetal form of the acetylcholine receptor distinguishes rhabdomyosarcomas from other childhood tumors.
Gattenloehner S, Vincent A, Leuschner I, Tzartos S, Muller-Hermelink H, Kirchner T
Am J Pathol. 1998; 152(2):437-44.
PMID: 9466570
PMC: 1857958.
Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation.
Tallini G, Parham D, Dias P, Cordon-Cardo C, Houghton P, Rosai J
Am J Pathol. 1994; 144(4):693-701.
PMID: 8160771
PMC: 1887248.